MAA
IART icon

Mraz Amerine & Associates’s Integra LifeSciences IART Stock Holding History

Mraz Amerine & Associates’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$174K Hold
10,700
– – 0.03% 178
2026
Q2 		$192K Hold
10,700
– – 0.03% 179
2026
Q1 		$101K Buy
+10,700
New +$117K 0.01% 181

Other funds holding IART

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Access Investment Management
Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Leeward Investments
Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mraz Amerine & Associates's IART Position: Q3 2026 in Review

Mraz Amerine & Associates held its Integra LifeSciences (IART) position steady in Q3 2026 at 10,700 shares worth $174K. The position accounts for 0.03% of the portfolio, ranked #178.

Mraz Amerine & Associates first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $192K in Q2 2026. 134 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Mraz Amerine & Associates held 10,700 shares of Integra LifeSciences worth $174K as of Q3 2026.
  • Mraz Amerine & Associates left its Integra LifeSciences share count unchanged in Q3 2026.
  • Integra LifeSciences made up 0.03% of Mraz Amerine & Associates's portfolio in Q3 2026, its #178 holding.
  • Mraz Amerine & Associates first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Mraz Amerine & Associates's Integra LifeSciences position peaked at $192K in Q2 2026.
  • 134 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Mraz Amerine & Associates's 13F filing for Q3 2026, filed 30 Oct 2026.